The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial

Chronic pancreatitis (CP) is a rare but debilitating condition with an 8-fold increased risk of developing pancreatic cancer. In addition to the symptoms that come from the loss of endocrine and exocrine function in CP, the management of chronic pain is problematic. We previously showed that the CCK...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pharmaceutics
المؤلفون الرئيسيون: Victor Ciofoaia, Wenqiang Chen, Bakain W. Tarek, Martha Gay, Narayan Shivapurkar, Jill P. Smith
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2024-04-01
الموضوعات:
chronic pancreatitis
cholecystokinin receptor
pain management
الوصول للمادة أونلاين:https://www.mdpi.com/1999-4923/16/5/611

الانترنت

https://www.mdpi.com/1999-4923/16/5/611

مواد مشابهة